Advertisement

Reactions Weekly

, Volume 1170, Issue 1, pp 3–3 | Cite as

CV disorder risks extend beyond COX-2-selectivity of NSAIDs

News item
  • 8 Downloads

Keywords

Celecoxib Naproxen Rofecoxib Ketorolac Meloxicam 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

REFERENCE

  1. 1.
    Graham DJ, Singh G, Wang H, Mannalithara A, Lingala V, Mithal A, Triadafilopoulos G.Risk of stroke in arthritis patients treated with Cox-2 selective and non-selective NSAIDs. Pharmacoepidemiology and Drug Safety 16 (Suppl. 2): 67, Aug 2007Google Scholar
  2. 2.
    Haag M, Breteler M, Stricker B.COX-selectivity of nonsteroidal antiinflammatory drugs and the risk of stroke. Pharmacoepidemiology and Drug Safety 16 (Suppl. 2): 67-68, Aug 2007Google Scholar
  3. 3.
    Miller DR, Kaufman DW, Lewis MA, Rahme E, Rosenberg L, Lelorier J, Cunningham F.NSAID use and risk of myocardial infarction in U.S. veterans. Pharmacoepidemiology and Drug Safety 16 (Suppl. 2): 68, Aug 2007Google Scholar
  4. 4.
    Lewis MA, Miller DR, Rahme E, Kühl-Habich D, Cunningham F, Kaufman DW, Rosenberg L, Lelorier J.Use of Cox-2 inhibitors, other NSAIDs, and the risk of myocardial infarction in three populations from UK, Canada, and the US. Pharmacoepidemiology and Drug Safety 16 (Suppl. 2): 68-69, Aug 2007Google Scholar

Copyright information

© Adis International limited or Adis Data Information BV 2007

Personalised recommendations